AstraZeneca PLC (AZN) operating KPIs
AZNNYSEPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Score 12/30
$163.95−1.46 (-0.88%)
Close on Oct 19, 2026Market cap $255.76BP/E 25.1Yield 1.91%
AstraZeneca total revenue ($M) ($M)
Form 6-K Quarterly & Form 20-F Revenue by Stream & Region Tables
Latest, Q2 2026
15,384
Period ended Jun 30, 2026
Change on a year earlier
+6.4%
14,457 in Q2 2025
History
42 quarters
Since Q1 2016
Sources
27
Documents cited below
Quarterly history
Hover a value to see the sentence it was read from; calculated values show their formula
Breakdown
What makes up total revenue ($m)
- Product sales ($M)14,510 · Q2 2026
- Alliance revenue ($M)874 · Q2 2026
- Collaboration revenue ($M)0 · Q2 2026
- United States (US) — Total revenue ($M)6,686 · Q2 2026
- Emerging Markets — Total revenue ($M)3,921 · Q2 2026
- Europe — Total revenue ($M)3,417 · Q2 2026
- Established Rest of World (Japan, Canada, Australia & New Zealand) — Total revenue ($M)1,361 · Q2 2026
Cite this data
StockData. (2026). AstraZeneca Total revenue ($M) ($M), quarterly Q1 2016–Q2 2026 [Data set]. Compiled from AstraZeneca SEC filings and investor materials. https://stockdatahq.com/stocks/azn/kpis/rev_total_disagg
See every metric in the AstraZeneca KPI table. Data updated Oct 28, 2026.